5 Reasons Arrowhead Pharma Is A Hepatitis B Leader
May 19, 2016 at 12:38 PM EDT
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) reported positive data in a Phase II study of its lead product ARC-520 for the treatment ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.